Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Company Profile Oncolix AEPP

Healthcare Biotechnology
Oncolix Inc is a clinical-stage biopharmaceutical company, which engages in the development of medical therapies for the treatment of various cancers including ovarian, breast, uterine, and prostate. It is developing Prolanta, a biological drug that is in Phase I clinical trial for the treatment of ovarian cancer.

Showcase News Releases

Showcase news

Prospera Energy Inc
Prospera Energy Inc. 2024 Corporate Update
i3 Energy Plc.
i3 Energy PLC Announces 2024 Capital Budget and Production Guidance
Africa Oil Corp.
AFRICA OIL ANNUAL GENERAL MEETING TO BE HELD ON MAY 23, 2024

More Showcase News Releases »